Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Lauren Hurwitz

Lauren M. Hurwitz, Ph.D., M.H.S.

Staff Scientist
Occupational and Environmental Epidemiology Branch

NCI Shady Grove | Room 6E612

240-276-7776
|
lauren.hurwitz@nih.gov

Biography

Lauren Hurwitz, Ph.D., is a staff scientist in the Occupational and Environmental Epidemiology Branch (OEEB). She came to DCEG as a postdoctoral fellow through the Cancer Prevention Fellowship Program, first in the Metabolic Epidemiology Branch and later in OEEB. During her fellowship, she studied modifiable risk factors, including aspirin use, pesticides, and obesity, in relation to prostate and ovarian cancer risk. She became a staff scientist in 2024. 

Dr. Hurwitz earned her Ph.D. in epidemiology in 2018, from the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, where she studied associations between use of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence, mortality, and recurrence. She has been recognized with several awards, including the Coleman Minority Health and Health Disparities Research Innovation Award, the Cancer Prevention Fellowship Program's Merit Award and Trans-Fellowship Research Award, and the NIH Fellows’ Award for Research Excellence.

Research Interests

Dr. Hurwitz supports research to investigate occupational, environmental, and lifestyle risk factors for cancer and conducts molecular epidemiologic studies to investigate potential carcinogenic mechanisms. She provides support for AsiaLymph, a large hospital-based case-control study of lymphoid and myeloid malignancies in East Asia, and for the Shanghai Women’s Health Study.

Email